As expected from the heterogeneity seen in clinical specimens of breast cancer, there was variability in expression of EGFR, from high expression in MDA-MB-468 and minimal expression in MDA-MB-435 cells (Figure 1A). The gene discussed is EGFR; the disease is breast carcinoma.